Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: A meta-analysis based on individual patient data

British Journal of Clinical Pharmacology

Volumn 54, Issue 3, 2002, Pages 320-326

  Lewis, S C ^a   Langman, M J S ^b,e   Laporte, Joan Ramon ^c   Matthews, John N S ^a   Rawlins, Michael D ^a   Wiholm, Bengt Erik ^d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Diclofenac; Dose response; Ibuprofen; Indomethacin; Ketoprofen; Meta analysis of individual patient data; Naproxen; Non aspirin nonsteroidal anti inflammatory drugs; Paracetamol (acetaminophen); Piroxicam; Upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0036378168     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01636.x     Document Type: Article

References (21)

1. Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485-494.
2. Langman MJS, Weil J, Wainright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078.
3. Laporte J-R, Carne X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991; 337: 85-89.
4. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 267: 6610-6614.
5. Committee on Safety of Medicines. Relative safety of oral non-aspirin nonsteroidal anti-inflammatory drugs. Current Problems Pharmacovigilance 1994; 20: 9.
6. Wright V. Historical overview of non-steroidal anti-inflammatory drugs. Br J Rheumatol 1995; 34(Suppl 1): 2
7. Rainsford KD. Aspirin and the Salicylates. Butterworths 1984
8. Belton KJ, Lewis SC, Matthew JNS, Rawlins MD. Systematic overview of upper gastrointestinal haemorrhage associated with non-steroidal anti-inflammatory drugs. In: Perspectives in Pharmacotoxicology and Pharmacovigilance, Ed. Fracchia, GN. Brussels: IOS Press, 1994.
9. Statistics and Epidemiology Research Corporation.EGRET. Seattle, Washington, USA, 1985
10. Statacorp. Stata Statistical Software, Release 4.0. College Station, TX: Stata Corporation, 1995.
11. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993; 105: 1078-1088.
12. MacDonald TM, Morant SV, Robinson GC, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study. Br Med J 1997; 315: 1333-1337.
13. Garcia Rodriguez LA, Hernandez-Dias S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001; 12: 570-576.
14. Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthritis Rheumatism 1993; 36: 84-90.
15. Garcia Rodriguez LA, Walker AM, Perez Gutthann S. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: A cohort study. Epidemiology 1992; 3: 337-342.
16. Henry DA, Lim LL-Y, Garcia-Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis. Br Med J 1996; 312: 1563-1566.
17. Slattery J, Warlow CP, Shorrock CJ, Langman MJS. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin- analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995; 37: 509-511
18. Chan FKL, Sung JJY, Chung SCS. Randomized controlled trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-979.
19. Cullen DJE, Hawkey GM, Greenwood DM, et al. Peptic ulcer bleeding in the elderly. Relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997; 459-562.
20. Hawkey CJ, Tulassey Z, Szczepanski L, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1997; 350: 1016-1021.
21. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.